摘要
目的:探讨环磷酰胺(CTX)+吡柔比星(THP)+氟尿嘧啶(FU)方案新辅助化疗后行乳腔镜保乳手术疗效及美容效果。方法:对2006年9月～2010年9月在本院行新辅助化疗联合保乳术治疗的30例早期乳腺癌患者的临床资料进行回顾性分析。结果:30例患者经治疗后客观有效率RR为93.3%,所有患者均存活,术后患者患侧乳房满意度好以上达到96.7%,部分患者出现不同程度骨髓抑制恶心、呕吐、脱发等不良反应,经处理后均可较好耐受。结论:早期乳腺癌采取新辅助化疗联合保乳术治疗,疗效显著,便于保乳并且美容效果好。
Objective：To investigate the cyclophosphamide （CTX） ＋ pirarubicin （THP） ＋ fluorouracil （FU） neoadjuvant chemotherapy underwent endoscopic breast conserving surgery and cosmetic results.Methods：From September 2006 to September 2010 in our hospital neoadjuvant chemotherapy and breast-conserving surgery for early breast cancer patients 30 patients were retrospectively analyzed.Results：30 patients with objective response rate after treatment RR was 93.3%,all patients were alive after a good patient satisfaction more than ipsilateral breast 96.7%,in some patients with varying degrees of bone marrow suppression,nausea,vomiting,hair loss and other adverse reactions,after treatment may be better tolerated.Conclusion：Early breast cancer to neoadjuvant chemotherapy and breast-conserving treatment,a significant effect,easy and cosmetic results of breast-conserving good.
出处
《中国当代医药》
2011年第10期30-31,共2页
China Modern Medicine
关键词
早期乳腺癌
新辅助化疗
保乳术
临床效果
With early breast cancer
Neoadjuvant chemotherapy
Conserving surgery
Clinical effect
